The Feasibility and Safety of RK-4 Injection Bypassing Blood-brain Barrier in the Treatment of Acute Large Hemispheric Infarction Using Intracalvariosseous Injection Device
Clinical trial NCT07514949 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07514949
- Sponsor
- yilong Wang
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-15
- Primary completion
- 2026-11-15
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.